2024/09/20 09:19:19 | |
---|---|
Price | |
79.83 EUR | |
Difference | -0.27% (-0.22) |
ISIN | US0126531013 |
Symbol | ALB |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 9,409 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 79.00 EUR (200) |
Ask (Ask size) | 79.37 EUR (200) |
Open | 79.94 EUR |
High | 79.94 EUR |
Low | 79.81 EUR |
Close (prev. day) | 80.05 EUR |
VWAP | - |
Volume (pcs) | 400 |
Trading volume | 31,928.00 |
Number of trades | 3 |
Last size | 200 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/20 09:19:19 | |
---|---|
Price | |
79.83 EUR | |
Difference | -0.27% (-0.22) |
ISIN | US0126531013 |
Symbol | ALB |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 9,409 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 79.00 EUR (200) |
Ask (Ask size) | 79.37 EUR (200) |
Open | 79.94 EUR |
High | 79.94 EUR |
Low | 79.81 EUR |
Close (prev. day) | 80.05 EUR |
VWAP | - |
Volume (pcs) | 400 |
Trading volume | 31,928.00 |
Number of trades | 3 |
Last size | 200 |
6m | 1Y | 3Y | |
Perf (%) | -27.92% | -52.22% | -58.45% |
Perf (abs.) | -31.01 | -87.49 | -112.60 |
Beta | 2.00 | 2.24 | 1.57 |
Volatility | 52.80 | 58.02 | 53.62 |
Ø price 5 days | Ø volume 5 days (pcs.) | 79.44 EUR (232) |
Ø price 30 days | Ø volume 30 days (pcs.) | 76.40 EUR (209) |
Ø price 100 days | Ø volume 100 days (pcs.) | 92.26 EUR (172) |
Ø price 250 days | Ø volume 250 days (pcs.) | 108.78 EUR (237) |
YTD High | date | 133.46 EUR (2024/01/03) |
YTD Low | date | 65.82 EUR (2024/08/14) |
52 Weeks High | date | 168.82 EUR (2023/09/20) |
52 Weeks Low | date | 65.82 EUR (2024/08/14) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/09/20 | 11:18 | 79.57 EUR | 0.00 | 1 |
Vienna Stock Exchange | 2024/09/20 | 11:00 | 79.23 EUR | 0.00 | 2 |
Tradegate | 2024/09/20 | 11:10 | 79.47 EUR | 0.05 | 10 |
Stuttgart | 2024/09/20 | 09:19 | 79.83 EUR | 0.03 | 3 |
NYSE | 2024/09/19 | 22:00 | 89.33 USD | 176.29 | 36,357 |
Munich | 2024/09/20 | 08:01 | 79.83 EUR | 0.00 | 1 |
London Stock Exchange | 2024/09/05 | 17:08 | 83.5445 USD | 0.00 | 1 |
Hamburg | 2024/09/20 | 08:01 | 79.84 EUR | 0.00 | 1 |
Frankfurt | 2024/09/20 | 08:50 | 79.91 EUR | 0.00 | 2 |
Duesseldorf | 2024/09/20 | 09:31 | 79.44 EUR | 0.00 | 2 |
Berlin | 2024/09/20 | 10:50 | 79.19 EUR | 0.00 | 4 |
ALBEMARLE CORP. |
- - |
4250 Congress Street, Suite 900 - 28209 Charlotte |
Telefon: +1-980-299-5700 |
Fax: + |
E-mail: - |
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, Ketjen, and All Other. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The All Other segment refers only to the FCS business that did not fit into any of the companyšs core businesses. The company was founded in 1993 and is headquartered in Charlotte, NC. |
Ralf Cramer | Member of Board of Directors |
Alejandro Wolff | Member of Board of Directors |
Dean Seavers | Member of Board of Directors |
Diarmuid O'Connell | Member of Board of Directors |
Gerald Steiner | Member of Board of Directors |
Glenda Minor | Member of Board of Directors |
Holly van Deursen | Member of Board of Directors |
James O'Brien | Member of Board of Directors |
Mary Brlas | Member of Board of Directors |
J. Kent Masters | Chairman of Managing Board |
Eric W. Norris | Member of Executive Committee |
Jac Fourie | Member of Executive Committee |
Kristin M. Coleman | Member of Executive Committee |
Melissa Anderson | Member of Executive Committee |
Neal Sheorey | Member of Executive Committee |
Netha Johnson | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer